Primary Care

Dermatomyositis

Questions discussed in this category

Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?

2 Answers available

Are there situations in which you treat calcinosis cutis that is not symptomatic for the patient?

Given the lack of efficacy of most treatment options, do you generally try to treat calcinosis cutis that is not bothering the patient even if it is q...

2 Answers available

What would be your next step in management of a dermatomyositis patient on hydroxychloroquine and methotrexate whose skin is still active?

Muscle disease is quiescent and no other manifestations such as ILD

1 Answer available

Papers discussed in this category

Medicine, 2021 Jan 08

Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").

Curr Rheumatol Rep, 2023 Aug

Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.

NeoReviews, 2021 Jan

Update on the Use of Intravenous Immunoglobulin in Pregnancy.

Journal of clinical pharmacology, 2023 Jun

Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.

Primary Care

Dermatomyositis

Questions discussed in this category

Papers discussed in this category

Related Topics in Primary Care